Clinical Trial Update: Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing fixed-dose cariprazine versus placebo for depressive episodes in Bipolar I Disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Bipolar Disorder, Depression | Phase 3 | Status: COMPLETED | Results posted: 2019-02-05